Urethral recurrence in patients with orthotopic ileal neobladders

被引:152
作者
Freeman, JA
Tarter, TA
Esrig, D
Stein, JP
Elmajian, DA
Chen, SC
Groshen, S
Lieskovsky, G
Skinner, DG
机构
[1] UNIV SO CALIF,SCH MED,DEPT UROL,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,SCH MED,DEPT PREVENT MED,LOS ANGELES,CA 90033
[3] UNIV SO CALIF,KENNETH NORRIS JR COMPREHENS CANC CTR,LOS ANGELES,CA 90033
关键词
urinary diversion; bladder; urethra; urethral neoplasms;
D O I
10.1016/S0022-5347(01)65462-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We identified the risk of urethral recurrence following cystectomy for transitional cell bladder carcinoma, stratified by pathological characteristics of the bladder tumor and type of urinary diversion. Materials and Methods: The pathological characteristics and clinical courses of 174 men with a Kock ileal neobladder and 262 with a cutaneous urinary diversion were analyzed for time to urethral recurrence. Results: Urethral recurrence was identified in 34 patients at a median of 1.6 years after cystectomy, for an overall 7.9% 5-year risk of recurrence. Carcinoma in situ (p = 0.71) and multifocality (p = 0.17) did not independently confer an increased risk of recurrence. Prostatic urethral involvement, particularly stromal invasion, significantly increased the probability of recurrence (p < 0.001). Patients with a Kock ileal neobladder had a significantly lower probability of recurrence compared to those with cutaneous diversion (p = 0.015), even when associated with prostatic urethral involvement. Conclusions: Patients with a Kock ileal neobladder have a lower risk of urethral recurrence than those with cutaneous urinary diversion, even when associated with a high risk pathological condition predicting increased risk of urethral recurrence.
引用
收藏
页码:1615 / 1619
页数:5
相关论文
共 22 条
[1]   ENTERIC ADENOMA AND ADENOCARCINOMA [J].
COOPER, MJ ;
WILLIAMSON, RCN ;
CHIR, M .
WORLD JOURNAL OF SURGERY, 1985, 9 (06) :914-920
[2]  
Crocitto Laura E., 1994, Journal of Urology, V151, p379A
[3]   MULTIDRUG RESISTANCE AND MUTAGENESIS [J].
FERGUSON, LR ;
BAGULEY, BC .
MUTATION RESEARCH, 1993, 285 (01) :79-90
[4]  
FREEMAN JA, 1994, UROL CLIN N AM, V21, P645
[5]   ON THE USE OF CAUSE-SPECIFIC FAILURE AND CONDITIONAL FAILURE PROBABILITIES - EXAMPLES FROM CLINICAL ONCOLOGY DATA [J].
GAYNOR, JJ ;
FEUER, EJ ;
TAN, CC ;
WU, DH ;
LITTLE, CR ;
STRAUS, DJ ;
CLARKSON, BD ;
BRENNAN, MF .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1993, 88 (422) :400-409
[6]   THE FUNCTION OF GP170, THE MULTIDRUG-RESISTANCE GENE-PRODUCT, IN THE BRUSH-BORDER OF RAT INTESTINAL-MUCOSA [J].
HSING, S ;
GATMAITAN, Z ;
ARIAS, IM .
GASTROENTEROLOGY, 1992, 102 (03) :879-885
[7]   SMALL INTESTINAL CYTOCHROMES-P450 [J].
KAMINSKY, LS ;
FASCO, MJ .
CRITICAL REVIEWS IN TOXICOLOGY, 1992, 21 (06) :407-422
[8]  
KATO M, 1990, J JAP SURG SOC, V91, P851
[9]   URINARY-DIVERSION VIA A CONTINENT ILEAL RESERVOIR - CLINICAL-RESULTS IN 12 PATIENTS [J].
KOCK, NG ;
NILSON, AE ;
NILSSON, LO ;
NORLEN, LJ ;
PHILIPSON, BM ;
GOODWIN, WE .
JOURNAL OF UROLOGY, 1982, 128 (03) :469-475
[10]  
LIESKOVSKY G, 1991, PROBL UROL, V5, P256